DiscoverManufacturing Tomorrow
Manufacturing Tomorrow
Claim Ownership

Manufacturing Tomorrow

Author: Ohio Manufacturing Institute

Subscribed: 53Played: 647
Share

Description

Manufacturing Tomorrow is a podcast series brought to you by the Ohio Manufacturing Institute at The Ohio State University. Featuring the perspectives of manufacturing leaders, we focus on the advanced manufacturing innovations, solutions and partnerships that exist in our region now and that will propel industry in the future.Our guests include the unsung heroes of advanced manufacturing, from company C-suite executives and engineers to industry-facing academics, supportive government agencies and regional economic development organizations. Interviews cover the latest topics on products, processes – and groundbreaking relationships –the best manufacturers engage in to infuse entrepreneurialism in their daily operations.Our mission is simple: to provide a voice to manufacturers to educate the public on the value of manufacturing innovation to the U.S. economy and to showcase how Ohio’s technology resource support providers (e.g., higher education, technical centers, and MEPs) boost advanced manufacturing solutions. We ask guest speakers about catalysts needed to collaborate on manufacturing innovation, how to reduce academic-industry barriers, and technical resources that can truly bolster manufacturing productivity.
132 Episodes
Reverse
When a machine goes down, a small or mid-sized manufacturer can lose time, product, and customer commitments. The problem grows as experienced machinists and technicians retire and take their troubleshooting knowledge with them. In this episode, we talk with two leaders from Madison, Wisconsin, about using AI to close that gap. Daniel Rogge is CEO of Tormach, an employee-owned maker of compact, affordable CNC mills, lathes, routers, and automation tools. Tormach designs, sells, and supports machines for schools, makers, and production shops. Daniel’s background spans professional metal fabrication, teaching, motion control engineering, and software development. Brian Kaufman is Chief Product Officer and Co-Founder of Strudel, an AI company founded in 2024 that helps teams find the root cause of a technical issue and get fix-ready context to the right person faster. He is a 20-year software product veteran who founded Janus Health and previously worked at Epic, Huron, and XSell. In this conversation, they discuss the operations technology challenges Tormach’s customers raise most often, what downtime costs a small or mid-sized manufacturer, and how retirements are changing the way shops handle maintenance and troubleshooting. They explain why Tormach brought in Strudel and how Strudel captures the knowledge that lives in a veteran technician’s head, the common faults they see, such as CNC startup faults and conveyor jams, and the patterns that surprised them. They finish with how to trust and verify an AI-suggested fix before acting on it, and a practical first step for small maintenance teams to capture and use their own troubleshooting knowledge. Keywords: manufacturing AI, predictive maintenance, CNC machining, workforce knowledge transfer
Manufacturing output is at its highest level since 2021, but can logistics networks keep up? On this episode of Manufacturing Tomorrow, Vinny Licata, Director of Logistics at MISUMI Americas, a global supplier of customizable factory automation components offers his read on today’s manufacturing logistics and supply chains. Vinny has more than 25 years in manufacturing logistics, including 15 years at Fairchild Semiconductor and more recently leading global logistics and import compliance at Fictiv and now MISUMI Americas. He has managed networks serving more than 40 countries. Momentum meets capacity. Production has now expanded for ten straight months, and new orders for eight. Vinny points to a surprising signal: in July, shipment volumes fell 4.8% year over year while freight spending rose 9.1%. Manufacturers are paying more to move less, which suggests that capacity, not demand, is the bottleneck, especially in the LTL market. Building flexibility before you need it. Vinny says flexibility is hard to add in the middle of a crisis. Manufacturers are moving from single sourcing to dual or triple sourcing, treating their supplier base like a financial portfolio, and leaning toward regionalization and bonded warehouses to manage tariff impact. Watching the road ahead. Vinny is watching the gap between capacity and demand. If demand accelerates while carriers are not adding capacity, the strain could compound. Lessons from the long view. Vinny’s central lesson is that partnerships have to mean something. More recently, he helped customers who were surprised by tariff charges by showing them landed cost and lead time by country of origin, and by educating them on product classification. His advice. Build optionality now by qualifying a second or third vendor and setting up alternate trade lanes. Treat trade policy as a variable input, not something to wait out. Track cost per shipment. And invest in true partnerships with both customers and vendors. Keywords: Manufacturing, Logistics, SupplyChain
Quality and compliance aren’t a regulatory checkbox — they’re a manufacturing advantage.That’s the philosophy Nour Abochama has built her career on. As Vice President of Operations at Qalitex Laboratories, an accredited testing lab with facilities in Irvine and San Diego, Nour brings more than 17 years in laboratory operations, quality assurance, and regulatory compliance to the table. A chemical engineer, entrepreneur, and life-sciences executive, she’s founded three laboratories and a pharmaceutical company — and she’s seen firsthand how strong quality systems accelerate growth instead of slowing it down.In this episode of Manufacturing Tomorrow, we dig into what it really takes to build resilient, scalable life-sciences manufacturing — and what those lessons mean for the future of U.S. advanced manufacturing and biomanufacturing. Keywords: life sciences manufacturing, quality and regulatory compliance, advanced manufacturing, biomanufacturing
On this episode of Manufacturing Tomorrow, we sit down with Richard Barnett, Chief Marketing Officer at Fusion Risk Management, a leading provider of operational resilience software and services. Richard has spent more than a decade working directly with manufacturing and supply chain organizations as their risk exposure has shifted alongside increasingly digitally connected operations. The conversation centers on a counterintuitive finding from Fusion’s latest Enterprise Resilience Report: manufacturers report feeling more prepared for disruption than they did in 2021. On the surface, that looks like progress. Richard argues it may actually be a warning sign — because the threats manufacturers have built confidence around aren’t the ones now emerging on the plant floor. The discussion digs into where that confidence gap shows up in practice: AI-driven incidents that most resilience frameworks haven’t caught up to, the risks hiding in IT/OT convergence for plants running legacy systems, and resilience exposure that lives entirely outside a manufacturer’s own four walls — in SaaS platforms and supply chain partners they don’t control. Richard also traces the shift underway in how resilience is treated organizationally — from a compliance checkbox to a strategic capability with real leadership attention and budget behind it — and closes with concrete first steps for any plant manager or VP of Operations who suspects they’ve got gaps. Keywords: Operational Resilience, IT/OT Convergence, Manufacturing Risk Management, AI in Manufacturing
Fabian Gerlinghaus, CEO and Co-Founder of Cellares, joins MFG TMW to discuss what it takes to manufacture living cell therapies at scale — and why doing it in America matters. Cellares operates the world’s first Integrated Development and Manufacturing Organization for automated cell therapy, runs Smart Factories in South San Francisco and Bridgewater, NJ, and recently earned the FDA’s first-ever Advanced Manufacturing Technology designation. We touch on supply chain security, the workforce implications of an 80% reduction in labor requirements, Cellares’ membership in the New American Industrial Alliance, and what its $600M+ in private capital signals about the future of domestic biomanufacturing. A must-listen for anyone thinking about the future of advanced, automated manufacturing. Keywords: Cell therapy manufacturing, automated biomanufacturing, supply chain security, reshoring / domestic manufacturing
loading
Comments